跳至主要内容
临床试验/NCT00665119
NCT00665119已完成4 期

Effects of Remifentanil on Breathing Pattern, Respiratory Effort and Gas Exchange in Mechanically Ventilated Patients.

Fondazione Poliambulanza Istituto Ospedaliero1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
14
试验地点
1
主要终点
respiratory rate/tidal volume

研究概览

简要总结

Sedation is widely used in mechanically ventilated patients. Propofol, benzodiazepines and opioids are the most used drugs. The study hypothesis is that sedation with remifentanil (an opioid drug) could improved respiratory pattern and effort in mechanically ventilated patients with rapid shallow breathing or high respiratory rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pressure support ventilation or CPAP
  • respiratory rate > 35.min-1
  • respiratory rate/tidal volume > 105

排除标准

  • vasoactive agents (dopamine lower than 5 mcg.kg-1.min-1 is not considered as vasoactive agent)
  • body temperature > 38 °C
  • Glasgow Coma Scale < 9
  • FIO2 > 0.6
  • PEEP > 10 cmH2O
  • pH < 7.30

研究组 & 干预措施

treatment

Experimental

Any patient alternatively receive both remifentanil and isotonic saline (placebo)infusion. The order of infusion is randomized. An interval of 30 minutes is planned between the two infusions.

干预措施: remifentanil (Drug)

treatment

Experimental

Any patient alternatively receive both remifentanil and isotonic saline (placebo)infusion. The order of infusion is randomized. An interval of 30 minutes is planned between the two infusions.

干预措施: placebo (Drug)

结局指标

主要结局

respiratory rate/tidal volume

时间窗: before and after remifentanil infusion; before and after placebo infusion.

pressure-time product

时间窗: before and after remifentanil infusion; before and after placebo infusion.

次要结局

  • double product of respiratory system(before and after remifentanil infusion; before and after placebo infusion.)
  • dynamic intrinsic PEEP(before and after remifentanil infusion; before and after placebo infusion.)
  • adverse events(during all the study period)
  • arterial pH(before and after remifentanil infusion; before and after placebo infusion.)
  • level of sedation (RASS)(before and after remifentanil infusion; before and after placebo infusion.)

研究者

发起方
Fondazione Poliambulanza Istituto Ospedaliero
申办方类型
Other

研究点 (1)

Loading locations...

相似试验